Back to announcements list
Issue of Equity and Total Voting Rights
RNS Number : 6848F
Triple Point Venture VCT PLC
05 March 2024
 

5 March 2024  

 

Triple Point Venture VCT Plc

(the "Company")

ISSUE OF EQUITY AND TOTAL VOTING RIGHTS

The Directors of Triple Point Venture VCT Plc (the "Company") are pleased to announce the allotment of 879,639 Venture Shares of 1p each at an average price of 98.433 pence per share on 5 March 2024 pursuant to the offer for subscription set out in a prospectus issued by the Company on 22 September 2023.

The shares allotted are to be admitted to the Official List. Admission is expected to become effective on or around 19 March 2024.

As a consequence of this allotment the issued share capital and total voting rights of the Company is now 63,993,259 Venture Class Shares.

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT:

   Triple Point Investment Management LLP

   (Investment Manager)

Tel: 020 7201 8989

   Ian McLennan

   Belinda Thomas


 

The Company's LEI is 213800AOOAQA5XQDEA89

Further information on the Company can be found on its website  https://www.triplepoint.co.uk/current-vcts/triple-point-venture-vct-plc/s2539/

NOTES:

The Company is a Venture Capital Trust incorporated in July 2010 and was established to fund small and medium sized enterprises. The Investment Manager is Triple Point Investment Management LLP.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEALDSELSLEFA